Neuroendocrine facets of human puberty

Neurobiology of Aging

Volumn 24, Issue SUPPL. 1, 2003, Pages

  Veldhuis, Johannes D ^a,b   Thijssen, ^c   Sultan, ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NONE

Author keywords

Bone; Child; Estrogen; Fat; GH; Human; IGF I; Muscle; Neonate; Puberty; Testosterone

Indexed keywords

ANDROGEN; ENDORPHIN; ENKEPHALIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; FOLLITROPIN; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HEXARELIN; IBUTAMOREN; LEPTIN; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; LUTEINIZING HORMONE; NEUROHORMONE; PRALMORELIN; SEX HORMONE; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; TESTOSTERONE;

BLOOD SAMPLING; CHILD DEVELOPMENT; CIRCADIAN RHYTHM; DRUG CLEARANCE; DRUG HALF LIFE; ENERGY BALANCE; ENTROPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN ACTIVITY; FEEDBACK SYSTEM; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE RELEASE; HORMONE STRUCTURE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHESIS; IMMUNOFLUORESCENCE TEST; IMMUNORADIOMETRIC ASSAY; LIPID STORAGE; LUTEINIZING HORMONE BLOOD LEVEL; METABOLIC DISORDER; NEGATIVE FEEDBACK; NERVE CELL; NERVE CELL STIMULATION; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PUBERTY; PULSATILE HORMONE RELEASE; RADIOIMMUNOASSAY; REVIEW; SEXUAL MATURATION; SIGNAL TRANSDUCTION;

EID: 0038537572     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00058-7     Document Type: Article

References (468)

1. Abbud R., Smith M.S. Differences in the luteinizing hormone and prolactin responses to multiple injections of kainate, as compared to N-methyl-D,L-aspartate, in cycling rats. Endocrinology. 129:1991;3254-3258.
2. Achermann J.C., Jameson J.L. Advances in the molecular genetics of hypogonadotropic hypogonadism. J. Pediatr. Endocrinol. Metab. 14:2001;3-15.
3. Achermann J.C., Weiss J., Lee E.J., Jameson J.L. Inherited disorders of the gonadotropin hormones. Mol. Cell. Endocrinol. 179:2001;89-96.
4. Adams L.A., Vician L., Clifton D.K., Steiner R.A. Testosterone regulates pro-opiomelanocortin gene expression in the primate brain. Endocrinology. 128:1991;1881-1886.
5. Agarwal S.K., Vogel K., Weitsman S.R., Magoffin D.A. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J. Clin. Endocrinol. Metab. 84:1999;1072-1076.
6. Ahima R.S., Dushay J., Flier S.N., Prabakaran D., Flier J.S. Leptin accelerates the onset of puberty in normal female mice. J. Clin. Invest. 99:1997;391-395.
7. Ahima R.S., Prabakaran D., Flier J.S. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J. Clin. Invest. 101:1998;1020-1027.
8. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E.et al. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
9. Aloi J.A., Bergendahl M., Iranmanesh A., Veldhuis J.D. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal-weight men. J. Clin. Endocrinol. Metab. 82:1997;1543-1548.
10. Amit T., Youdim M.B., Hochberg Z. Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function? J. Clin. Endocrinol. Metab. 85:2000;927-932.
11. Anderson S.M., Shah N., Patrie J.T., Evans W.S., Bowers C.Y., Veldhuis J.D. Short-term estradiol supplementation augments growth hormone (GH)-secretory responsiveness to dose-varying growth hormone-releasing peptide (GHRP-2) infusions in postmenopausal women. J. Clin. Endocrinol. Metab. 86:2000;551-560.
12. Anderson S.M., Wideman L., Patrie J.T., Weltman A., Bowers C.Y., Veldhuis J.D. Estradiol supplementation selectively relieves growth hormone (GH)'s autonegative feedback on GH-releasing peptide-2 (GHRP-2)-stimulated GH secretion. J. Clin. Endocrinol. Metab. 86:2002;5904-5911.
13. Andreelli F., Hanaire-Broutin H., Laville M., Tauber J.P., Riou J.P., Thivolet C. Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J. Clin. Endocrinol. Metab. 85:2000;715-719.
14. Apter D., Cacciatore B., Alfthan H., Stenman U.H. Serum luteinizing hormone concentrations increase 100-fold in females from 7 years of age to adulthood, as measured by time-resolved immunofluorometric assay. J. Clin. Endocrinol. Metab. 68:1989;53-57.
15. Argente J., Chowen B.J., Steiner R.A., Clifton D.K. Somatostatin messenger RNA in hypothalamic neurons is increased by testosterone through activation of androgen receptors and not by aromatization to estradiol. Neuroendocrinology. 52:1990;342-349.
16. Argente J., Chowen J.A., Zeitler P., Clifton D.K., Steiner R.A. Sexual dimorphism of growth hormone-releasing hormone and somatostatin gene expression in the hypothalamus of the rat during development. Endocrinology. 128:1991;2369-2375.
17. Arslanian S., Suprasongsin C. Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. J. Clin. Endocrinol. Metab. 82:1997;3213-3220.
18. Arvat E., Di Vito L., Gianotti L., Ramunni J., Boghen M.F., Deghenghi R.et al. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Metabolism. 46:1997;83-88.
19. Arvat E., Ramunni J., Bellone J., Di Vito L., Baffoni C., Broglio F.et al. The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations. Eur. J. Endocrinol. 1237:1997;635-642.
20. Aubert M.L., Pierroz D.D., Gruaz N.M., d'Alleves V., Vuagnat B.A., Pralong F.P.et al. Metabolic control of sexual function and growth: role of neuropeptide Y and leptin. Mol. Cell. Endocrinol. 140:1998;107-113.
21. Auger A.P., Tetel M.J., McCarthy M.M. Steroid receptor coactivator-1 (SRC-1) mediates the development of sex-specific brain morphology and behavior. Proc. Natl. Acad. Sci. U.S.A. 97:2000;7551-7555.
22. Aynsley-Green A., Zachmann M., Prader A. Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism. J. Pediatr. 89:1976;992-999.
23. Badger T.M., Millard W.J., McCormick G.F., Bowers C.Y., Martin J.B. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology. 115:1984;1432-1438.
24. Banfi G., Marinelli M., Pontillo M., Bonini P. Standardization with synthetic 22-kDa monomer human growth hormone reduces discrepancies between two monoclonal immunoradiometric assay kits. Clin. Chem. 38:1992;2107-2110.
25. Barb C.R., Barrett J.B., Kraeling R.R., Rampacek G.B. Serum leptin concentrations, luteinizing hormone and growth hormone secretion during feed and metabolic fuel restriction in the prepuberal gilt. Domest. Anim. Endocrinol. 20:2001;47-63.
26. Baumann G., Amburn K., Shaw M.A. The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. Endocrinology. 122:1988;976-984.
27. Baumann G., Shaw M.A. A second, lower affinity growth hormone-binding protein in human plasma. J. Clin. Endocrinol. Metab. 70:1990;680-686.
28. Baumann G., Stolar M.W., Buchanan T.A. The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms. Endocrinology. 119:1986;1497-1501.
29. Baumann G., Stolar M.W., Buchanan T.A. The effect of circulating growth hormone binding protein on metabolic clearance, distribution and degradation of human growth hormone. J. Clin. Endocrinol. Metab. 64:1987;657-660.
30. Baumbach W.R., Carrick T.A., Pausch M.H., Bingham B., Carmignac D., Robinson I.C.et al. A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Mol. Pharmacol. 54:1998;864-873.
31. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V.et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43:2000;4370-4376.
32. Bellantoni M.F., Harman S.M., Cho D.E., Blackman M.R. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J. Clin. Endocrinol. Metab. 72:1991;172-178.
33. Bellone J., Aimaretti G., Bartolotta E., Benso L., Imbimbo B.P., Lenhaerts V.et al. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. J. Clin. Endocrinol. Metab. 80:1995;1090-1094.
34. Bellone J., Bellone S., Aimaretti G., Valetto M.R., Baffoni C., Corneli G.et al. The negative GH autofeedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children. J. Endocrinol. Invest. 23:2000;158-162.
35. Bellone J., Ghizzoni L., Aimaretti G., Volta C., Boghen M.F., Bernasconi S.et al. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Eur. J. Endocrinol. 133:1995;425-429.
36. Benitez L., Mallo F., Alvarez C.V., Burguera B., Sanchez-Franco F., Dieguez C. Estrogen-dependent effects of bombesin on in vivo growth hormone secretion in the rat. Neuroendocrinology. 52:1990;608-611.
37. Bennett P.A., Levy A., Sophokleous S., Robinson I.C., Lightman S.L. Hypothalamic GH receptor gene expression in the rat: effects of altered GH status. J. Endocrinol. 147:1995;225-234.
38. Bennett P.A., Thomas G.B., Howard A.D., Feighner S.D., van der Ploeg L.H., Smith R.G.et al. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology. 138:1997;4552-4557.
39. Bergendahl M., Evans W.S., Pastor C.L., Patel A., Iranmanesh A., Veldhuis J.D. Short-term fasting suppresses leptin and (conversely) activates disorderly GH secretion in mid-luteal phase women. J. Clin. Endocrinol. Metab. 84:1999;883-894.
40. Bergendahl M., Evans W.S., Veldhuis J.D. Current concepts on ultradian rhythms of luteinizing hormone secretion in the human. Hum. Reprod. Update. 2:1996;507-518.
41. Bergendahl M., Iranmanesh A., Evans W.S., Veldhuis J.D. Short-term fasting selectively suppresses leptin pulse mass and 24-h rhythmic leptin release in healthy mid-luteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). J. Clin. Endocrinol. Metab. 85:2000;207-213.
42. Bergendahl M., Iranmanesh A., Pastor C., Evans W.S., Veldhuis J.D. Homeostatic joint amplification of pulsatile and 24-h rhythmic cortisol secretion by fasting stress in midluteal phase women: concurrent disruption of cortisol-growth hormone, cortisol-luteinizing hormone, and cortisol-leptin synchrony. J. Clin. Endocrinol. Metab. 85:2000;4028-4035.
43. Bergendahl M., Veldhuis J.D. Altered pulsatile gonadotropin signaling in nutritional deficiency in the male. Trends Endocrinol. Metab. 6:1995;145-159.
44. Blache D., Celi P., Blackberry M.A., Dynes R.A., Martin G.B. Decrease in voluntary feed intake and pulsatile luteinizing hormone secretion after intracerebroventricular infusion of recombinant bovine leptin in mature male sheep. Reprod. Fertil. Dev. 12:2000;373-381.
45. Blethem S.L., Chasalow F.I. Use of a two-site immunoradiometric assay for growth hormone in identifying children with GH-independent growth failure. J. Clin. Endocrinol. Metab. 57:1983;1031-1035.
46. Bloch C.A., Clemons P., Sperling M.A. Puberty decreases insulin sensitivity. J. Pediatr. 110:1987;481-487.
47. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Muller J.et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J. Clin. Endocrinol. Metab. 82:1997;2904-2910.
48. Blumenfeld Z., Barkey R.J., Youdim M.B., Brandes J.M., Amit T. Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in human: the effect of ovulation induction with menopausal gonadotropins, GH, and gestation. J. Clin. Endocrinol. Metab. 75:1992;1242-1249.
49. Bourguignon J.P., Gerard A., Alvarez-Gonzalez M.L., Fawe L., Franchimont P. Gonadal-independent development changes in activation of N-methyl-D-aspartate receptors involved in gonadotropin-releasing hormone secretion. Neuroendocrinology. 55:1992;634-641.
50. Bourguignon J.P., Gerard A., Franchimont P. Direct activation of gonadotropin-releasing hormone secretion through different receptors to neuroexcitatory amino acids. Neuroendocrinology. 49:1989;402-408.
51. Bowers C.Y., Momany F.A., Reynolds A., Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1984;1537-1545.
52. Brandenberger G., Gronfier C., Chapotot F., Simon C., Piquard F. Effect of sleep deprivation on overall 24 h growth-hormone secretion. Lancet. 356:2000;1408.
53. Bray M.J., Vick T.M., Shah N., Anderson S.M., Rice L.W., Iranmanesh A.et al. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. J. Clin. Endocrinol. Metab. 86:2001;3143-3149.
54. Brill K.T., Weltman A.L., Gentili A., Patrie J.T., Fryburg D.A., Hanks J.B.et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J. Clin. Endocrinol. Metab. 87:2002;5649-5657.
55. Bruns C., Weckbecker G., Raulf F., Lubbert H., Hoyer D. Characterization of somatostatin receptor subtypes. Ciba Found. Symp. 190:1995;89-101.
56. Buckler H.M., Phillips S.E., Cameron I.T., Healy D.L., Burger H.G. Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 67:1988;300-306.
57. Burbridge D., Wallis M. Actions of monoclonal antibodies on the activity of human growth hormone (GH) in an in vitro bioassay. Mol. Cell. Endocrinol. 174:2001;11-19.
58. Buscail L., Delesque N., Esteve J.P., Saint-Laurent N., Prats H., Clerc P.et al. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2315-2319.
59. Butler J.A., Sjoberg M., Coen C.W. Evidence for oestrogen receptor alpha-immunoreactivity in gonadotrophin-releasing hormone-expressing neurones. J. Neuroendocrinol. 11:1999;331-335.
60. Cagampang F.R., Cates P.S., Sandhu S., Strutton P.H., McGarvey C., Coen C.W.et al. Hypoglycaemia-induced inhibition of pulsatile luteinizing hormone secretion in female rats: role of oestradiol, endogenous opioids and the adrenal medulla. J. Neuroendocrinol. 9:1997;867-872.
61. Calabresi E., Ishikawa E., Bartolini L., Delitala G., Fanciulli G., Oliva O.et al. Somatostatin infusion suppresses GH secretory burst number and mass in normal men: a dual mechanism of inhibition. Am. J. Physiol. 270:1996;E975-E979.
62. Campagnoli C., Biglia N., Altare F., Lanza M.G., Lesca L., Cantamessa C.et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor I, growth hormone and sex hormone binding globulin serum levels. Gynecol. Endocrinol. 7:1993;251-258.
63. Cara J.F., Burstein S., Cuttler G.L., Moll G.W., Rosenfeld R.L. Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty. J. Pediatr. 115:1989;64-68.
64. Carlsson L.M., Clark R.G., Robinson I.C. Sex difference in growth hormone feedback in the rat. J. Endocrinol. 126:1990;27-35.
65. Carmignac D.F., Flavell D.M., Robinson I.C. Pituitary growth hormone releasing factor receptor expression in normal and dwarf rats. Neuroendocrinology. 64:1996;177-185.
66. Carro E., Seoane L.M., Senaris R., Considine R.V., Casanueva F.F., Dieguez C. Interaction between leptin and neuropeptide Y on in vivo growth hormone secretion. Neuroendocrinology. 68:1998;187-191.
67. Casanueva F.F., Dieguez C. Neuroendocrine regulation and actions of leptin. Front. Neuroendocrinol. 20:1999;317-363.
68. Caufriez A. The pubertal spurt: effects of sex steroids on growth hormone and insulin-like growth factor I. Eur. J. Obstet. Gynecol. Reprod. Biol. 71:1997;215-217.
69. Cemeroglu A.P., Foster C.M., Warner R., Kletter G.B., Marshall J.C., Kelch R.P. Comparison of the neuroendocrine control of pubertal maturation in girls and boys with spontaneous puberty and hypogonadal girls. J. Clin. Endocrinol. Metab. 81:1996;4352-4357.
70. Chalew S.A., Udoff L.C., Hanukoglu A., Bistritzer T., Armour K.M., Kowarski A.A. The effect of testosterone therapy on spontaneous growth hormone secretion in boys with constitutional delay. Am. J. Dis. Child. 142:1989;1345-1348.
71. Chan Y.Y., Steiner R.A., Clifton D.K. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology. 137:1996;1319-1325.
72. Chapman I.M., Hartman M.L., Pieper K.S., Skiles E.H., Pezzoli S.S., Hintz R.L.et al. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J. Clin. Endocrinol. Metab. 83:1998;2836-2842.
73. Chapman I.M., Hartman M.L., Straume M., Johnson M.L., Veldhuis J.D., Thorner M.O. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J. Clin. Endocrinol. Metab. 78:1994;1312-1319.
74. Chen M.D., Ordog T., O'Byrne K.T., Goldsmith J.R., Connaughton M.A., Knobil E. The insulin hypoglycemia-induced inhibition of gonadotropin-releasing hormone pulse generator activity in the rhesus monkey: role of vasopressin and corticotropin-releasing factor. Endocrinology. 137:1996;2012-2021.
75. Chen Z., Zheng H., Dong K.W. Identification of negative and positive estrogen response elements in human GnRH upstream promoter in the placental JEG-3 cells. Mol. Cell. Endocrinol. 184:2001;125-134.
76. Choi I., Ko C., Park-Sarge O.K., Nie R., Hes R.A., Graves C.et al. Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues. Mol. Cell. Endocrinol. 181:2001;139-150.
77. Choi M.S., Cooke B.A. Calmidazolium is a potent stimulator of steroidogenesis via mechanisms not involving cyclic AMP, calcium or protein synthesis. Biochem. J. 281:1992;291-296.
78. Chowen J.A., Argente J., Gonzalez-Parra S., Garcia-Segura L.M. Differential effects of the neonatal and adult sex steroid environments on the organization and activation of hypothalamic growth hormone-releasing hormone and somatostatin neurons. Endocrinology. 133:1993;2792-2802.
79. Clark P.A., Iranmanesh A., Veldhuis J.D., Rogol A.D. Comparison of pulsatile luteinizing hormone secretion between prepubertal children and young adults: evidence for a mass/amplitude-dependent difference without gender or day/night contrasts. J. Clin. Endocrinol. Metab. 82:1997;2950-2955.
80. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D.et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:1998;398-401.
81. Copinschi G., Van Cauter E. Pituitary hormone secretion in aging: role of circadian rhythmicity and sleep. Eur. J. Endocrinol. 131:1994;441-442.
82. Copinschi G., Van Cauter E. Effects of ageing on modulation of hormonal secretions by sleep and circadian rhythmicity. Horm. Res. 43:1995;20-24.
83. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20:1999;358-417.
84. Craft W.H., Underwood L.E. Effect of androgens on plasma somatomedin-C/insulin-like growth factor 1 responses to growth hormone. Clin. Endocrinol. 20:1984;549-554.
85. Cuneo R.C., Hickman P., Wallace J.D., Teh B.T., Ward G., Veldhuis J.D.et al. Altered endogenous growth factor (GH) secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin. Endocrinol. 43:1995;265-275.
86. Cunningham M.J., Clifton D.K., Steiner R.A. Leptin's actions on the reproductive axis: perspectives and mechanisms. Biol. Reprod. 60:1999;216-222.
87. Curtin D., Jenkins S., Farmer N., Anderson A.C., Haisenleder D.J., Rissman E.et al. Androgen suppression of GnRH-stimulated rat LHbeta gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Mol. Endocrinol. 15:2001;1906-1917.
88. Cuttler L., Van Vliet G., Conte F.A., Kaplan S.L., Grumbach M.M. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy. J. Clin. Endocrinol. Metab. 60:1985;1087-1092.
89. Date Y., Kojima M., Hososda H., Sawaguchi A., Mondaie M.S., Suganuma T.et al. Ghrelin, a novel growth-hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastro-intestinal tracts of rats and humans. Endocrinology. 141:2000;4261-4267.
90. Date Y., Murakami N., Kojima M., Kuroiwa T., Matsukura S., Kangawa K.et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun. 275:2000;477-480.
91. Daughaday W.H., Trivedi B., Winn H.N., Yan H. Hypersomatotropism in pregnant women, as measured by a human liver radioreceptor assay. J. Clin. Endocrinol. Metab. 70:1990;215-221.
92. Davey H.W., Wilkins R.J., Waxman D.J. STAT5 signaling in sexually dimorphic gene expression and growth patterns. Am. J. Hum. Genet. 65:1999;959-965.
93. Davidson J.S., McArdle C.A., Davies P., Elario R., Flanagan C.A., Millar R.P. Asn102 of the gonadotropin-releasing hormone receptor is a critical determinant of potency for agonists containing C-terminal glycinamide. J. Biol. Chem. 271:1996;15510-15514.
94. De Leo V., Lanzetta D., D'Antona D., Danero S. Growth hormone secretion in premenopausal women before and after ovariectomy: effect of hormone replacement therapy. Fertil. Steril. 60:1993;268-271.
95. De Roux N., Milgrom E. Inherited disorders of GnRH and gonadotropin receptors. Mol. Cell. Endocrinol. 179:2001;83-87.
96. de Zegher F., Vanderschueren-Lodeweyckx M., Spitz B. Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH. J. Clin. Endocrinol. Metab. 77:1990;520-522.
97. Delemarre-van de Waal H.A., Wennink J.M., Odink R.J. Gonadotrophin and growth hormone secretion throughout puberty. Acta Paediatr. Scand. (Suppl.). 372:1991;26-31.
98. Denef C. Paracrine mechanisms in the pituitary. In: Imura H, editor. The pituitary gland. 2nd ed. New York: Raven Press; 1994. p. 351-78.
99. Devesa J., Lois N., Arce V., Diaz M.J., Lima L., Tresguerres J.A. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans. J. Steroid Biochem. Mol. Biol. 40:1991;165-173.
100. Dickson S.L., Bailey A.R., Leng G. Growth hormone (GH) secretagogues and neuroendocrine regulation of GH secretion. Growth Horm. IGF Res. 9(Suppl. A):1999;89-91.
101. DiMartino-Nardi J., Wu R., Fishman K., Saenger P. The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty. J. Clin. Endocrinol. Metab. 73:1991;902-906.
102. Drop S.L., Sabbe-Claus L., Visser H.K. The effect of puberty and short-term oral administration of testosterone undecoanoate on GH tests and sex-steroid related plasma compounds in GH deficient patients. Clin. Endocrinol. 16:1982;375-381.
103. Dudas B., Mihaly A., Merchenthaler I. Topography and associations of luteinizing hormone-releasing hormone and neuropeptide Y-immunoreactive neuronal systems in the human diencephalon. J. Comp. Neurol. 427:2000;593-603.
104. Dufourny L., Warembourg M. Colocalization of progesterone receptor and somatostatin immunoreactivities in the hypothalamus of the male and female guinea pig. Neuroendocrinology. 64:1996;215-224.
105. Eakman G.D., Dallas J.S., Ponder S.W., Keenan B.S. The effect of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J. Clin. Endocrinol. Metab. 81:1996;1217-1223.
106. Ebling F.J., Hui Y., Mirakhur A., Maywood E.S., Hastings M.H. Photoperiod regulates the LH response to central glutamatergic stimulation in the male Syrian hamster. J. Neuroendocrinol. 5:1993;609-618.
107. Eddy E.M., Washburn T.F., Bunch D.O., Goulding E.H., Gladen B.C., Lubahn D.B.et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology. 137:1996;4796-4805.
108. Eliakim A., Scheett T.P., Newcomb R., Mohan S., Cooper D.M. Fitness, training, and the growth hormone → insulin-like growth factor I axis in prepubertal girls. J. Clin. Endocrinol. Metab. 86:2001;2797-2802.
109. Ellis S., Vodian M.A., Grindeland R.E. Studies on the bioassayable growth hormone-like activity of plasma. Recent Prog. Horm. Res. 34:1978;213-238.
110. Elmquist J.K., Ahima R.S., Maratos-Flier E., Flier J.S., Saper C.B. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology. 138:1997;839-842.
111. Erickson J.C., Hollopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:1996;1704-1707.
112. Estupina C., Pinter A., Belmar J., Astier H., Arancibia S. Variations in hypothalamic somatostatin release and content during the estrous cycle in the rat. Effects of ovariectomy and estrogen supplementation. Neuroendocrinology. 63:1996;181-187.
113. Evans J.J. Modulation of gonadotropin levels by peptides acting at the anterior pituitary gland. Endocr. Rev. 20:1999;46-67.
114. Evans W.S., Anderson S.M., Hull L.T., Azimi P.P., Bowers C.Y., Veldhuis J.D. Continuous 24-h intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1,44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. J. Clin. Endocrinol. Metab. 86:2001;700-712.
115. Evans WS, Bowers CY, Veldhuis JD. Estradiol supplementation enhances pituitary sensitivity to recombinant human (RH) GHRH-1,44-amide in somatostatin (SS)-withdrawn postmenopausal women. Presented at the Endocrine Society 83rd Meeting, 2001 June 20-23; Denver, CO.
116. Evans W.S., Krieg R.J. Jr., Limber E.R., Kaiser D.L., Thorner M.O. Effects of in vivo gonadal hormone environment on in vitro hGRF-40-stimulated GH release. Am. J. Physiol. 249:1985;E276-E280.
117. Evans W.S., Sollenberger M.J., Booth R.A. Jr., Rogol A.D., Urban R.J., Carlsen E.C.et al. Contemporary aspects of discrete peak detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr. Rev. 13:1992;81-104.
118. Fairhall K.M., Mynett A., Robinson I.C. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J. Endocrinol. 144:1995;555-560.
119. Farhi L.S., Straume M., Johnson M.L., Kovatchev B.P., Veldhuis J.D. A construct of interactive feedback control of the GH axis in the male. Am. J. Physiol. 281:2001;R38-R51.
120. Faria A.C., Bekenstein L.W., Booth R.A. Jr., Vaccaro V.A., Asplin C.M., Veldhuis J.D.et al. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin. Endocrinol. 36:1992;591-596.
121. Farooqi I.S., Jebb S.A., Langmack G., Lawrence E., Cheetham C.H., Prentice A.M.et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New Engl. J. Med. 341:1999;879-884.
122. Ferro V.A., Khan M.A., Latimer V.S., Brown D., Urbanski H.F., Stimson W.H. Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use. J. Reprod. Immunol. 51:2001;109-129.
123. Fischbein S. Intra-pair similarity in physical growth of monozygotic and of dizygotic twins during puberty. Ann. Hum. Biol. 4:1977;417-430.
124. Fisher C.R., Graves K.H., Parlow A.F., Simpson E.R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6965-6970.
125. Flavell D.M., Wells T., Wells S.E., Carmignanc D.F., Thomas G.B., Robinson I.C. Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons. EMBO J. 15:1996;3871-3879.
126. Fletcher T.P., Thomas G.B., Clarke I.J. Growth hormone-releasing and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Domest. Anim. Endocrinol. 13:1996;251-258.
127. Flier J.S., Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell. 92:1998;437-440.
128. Ford H., Ebling F.J. Glutamatergic regulation of gonadotropin releasing hormone mRNA levels during development in the mouse. J. Neuroendocrinol. 12:2000;1027-1033.
129. Foster D.L., Nagatani S. Physiological perspectives on leptin as a regulator of reproduction: role in timing puberty. Biol. Reprod. 60:1999;205-215.
130. Friedman A.J., Rein M.S., Pandian M.R., Barbieri R.L. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo. Fertil. Steril. 53:1990;250-253.
131. Friend K., Iranmanesh A., Veldhuis J.D. The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days. J. Clin. Endocrinol. Metab. 81:1996;3746-3753.
132. Frisch R.E. Weight at menarche: similarity for well-nourished and undernourished girls at differing ages, and evidence for historical constancy. Pediatrics. 50:1972;445-450.
133. Frisch R.E., Gotz-Welbergen A.V., McArthur J.W. Delayed menarche and amneorrhea in college athletes in relation to age of onset of training. J. Am. Med. Assoc. 246:1982;1559-1563.
134. Frohman L.A., Kineman R.D., Kamegai J., Park S., Teixeira L.T., Coschigano K.T.et al. Secretagogues and the somatotrope: signaling and proliferation. Recent Prog. Horm. Res. 55:2000;269-290.
135. Fryburg D.A., Gelfand R.A., Barrett E.J. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am. J. Physiol. 260:1991;E499-E504.
136. Fryburg DA, Weltman A, Jahn LA, Weltman JY, Samojlik E, Hintz RL, et al. Androgenic modulation of the growth hormone-IGF axis and its impact on metabolic outcomes. In: Veldhuis JD, Giustina A, editors. Sex-steroid interactions with growth hormone. 1st ed. Part I. New York: Springer-Verlag; 1999. p. 82-92.
137. Fryburg D.A., Weltman A., Jahn L.A., Weltman J.Y., Samojlik E., Veldhuis J.D. Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men. J. Clin. Endocrinol. Metab. 82:1997;3710-3719.
138. Furukawa T., Ito H., Nitta J., Tsujino M., Adachi S., Hiroe M.et al. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ. Res. 71:1992;1242-1253.
139. Gabrielsson B.G., Carmignac D.F., Flavell D.M., Robinson I.C. Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology. 136:1995;209-217.
140. Gallo F., Morale M.C., Tirolo C., Testa N., Farinella Z., Avola R.et al. Basic fibroblast growth factor priming increases the responsiveness of immortalized hypothalamic luteinizing hormone releasing hormone neurones to neurotrophic factors. J. Neuroendocrinol. 12:2000;941-959.
141. Gamse R., Vaccaro D.E., Gamse G., DiPace M., Fox T.O., Leeman S.E. Release of immunoreactive somatostatin from hypothalamic cells in culture: inhibition by gamma-aminobutyric acid. Proc. Natl. Acad. Sci. U.S.A. 77:1980;5552-5556.
142. Gavin J., Trivedi B., Daughaday W.H. Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone. J. Clin. Endocrinol. Metab. 55:1982;133-139.
143. 2 in young adult men and women. J. Clin. Endocrinol. Metab. 59:1984;197-201.
144. Gentili A., Mulligan T., Godschalk M., Clore J., Patrie J., Iranmanesh A.et al. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J. Clin. Endocrinol. Metab. 87:2002;825-834.
145. Gevers E., Pincus S.M., Robinson I.C., Veldhuis J.D. Differential orderliness of the GH release process in castrate male and female rats. Am. J. Physiol. 274:1998;R437-R444.
146. Gevers E.F., Milne J., Robinson I.C., Loveridge N. Single cell enzyme activity and proliferation in the growth plate: effects of growth hormone. J. Bone Miner. Res. 11:1996;1103-1111.
147. Ghigo E, Arvat E, Gianotti L, Di Vito L, Broglio F, Muccioli G, et al. Endocrine response to growth hormone-releasing peptides across human life span. In: Bercu BB, Walker RF, editors. Growth hormone secretagogues in clinical practice. New York: Marcel Dekker Inc.; 1998. p. 345-67.
148. Ghigo E., Gianotti L., Arvat E., Ramunni J., Valetto M.R., Broglio F.et al. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans. J. Clin. Endocrinol. Metab. 84:1999;285-290.
149. Ghigo E., Goffi S., Mazza E., Arvat E., Procopio M., Bellone J.et al. Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children. Acta Endocrinol. 120:1989;598-601.
150. Gianotti L., Maccario M., Lanfranco F., Ramunni J., Di Vito L., Grottoli S.et al. Arginine counteracts the inhibitory effect of recombinant
151. Girard N., Boulanger L., Denis S., Gaudreau P. Differential in vivo regulation of the pituitary growth hormone-releasing hormone (GHRH) receptor by GHRH in young and aged rats. Endocrinology. 140:1999;2836-2842.
152. Giustina A., Scalvini T., Tassi C., Desenzani P., Poiesi C., Wehrenberg W.B.et al. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J. Clin. Endocrinol. Metab. 82:1997;1210-1219.
153. Giustina A., Veldhuis J.D. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human. Endocr. Rev. 19:1998;717-797.
154. Glaum S.R., Hara M., Bindokas V.P., Lee C.C., Polonsky K.C., Bell G.I.et al. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol. Pharmacol. 50:1996;230-235.
155. Glick S.M., Roth J., Yalow R.S., Berson S.A. Immunoassay of human growth hormone. Nature. 199:1963;784-787.
156. Goji K. Pulsatile characteristics of spontaneous growth hormone (GH) concentration profiles in boys evaluated by an ultrasensitive immunoradiometric assay: evidence for ultradian periodicity of GH secretion. J. Clin. Endocrinol. Metab. 76:1993;667-670.
157. Gondo R.G., Aguiar-Oliveira M.H., Hayashida C.Y., Toledo S.P., Abelin N., Levine M.A.et al. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. J. Clin. Endocrinol. Metab. 86:2001;3279-3283.
158. Goubillon M.L., Thalabard J.C. Insulin-induced hypoglycemia decreases luteinizing hormone secretion in the castrated male rat: involvement of opiate peptides. Neuroendocrinology. 64:1996;49-56.
159. Gross D.S. Role of somatostatin in the modulation of hypophysial growth hormone production by gonadal steroids. Am. J. Anat. 158:1980;507-519.
160. Guo F., Beaudet A., Tannenbaum G.S. The effect of hypophysectomy and growth hormone replacement on sst1 and sst2 somatostatin receptor subtype messenger ribonucleic acids in the arcuate nucleus. Endocrinology. 137:1996;3928-3935.
161. Haavisto A.M., Dunkel L., Pettersson K., Huhtaniemi I. LH measurements by in vitro bioassay and a highly sensitive immunofluorometric assay improve the distinction between boys with constitutional delay of puberty and hypogonadotropic hypogonadism. Pediatr. Res. 27:1990;211-214.
162. Haavisto A.M., Pettersson K., Bergendahl M., Virkamaki A., Huhtaniemi I. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J. Clin. Endocrinol. Metab. 80:1995;1257-1263.
163. Harjola V., Jankala H., Harkonen M. Myosin heavy chain mRNA and protein distribution in immobilized rat skeletal muscle are not affected by testosterone status. Acta Physiol. Scand. 169:2000;277-282.
164. Hartman M.L., Faria A.C., Vance M.L., Johnson M.L., Thorner M.O., Veldhuis J.D. Temporal structure of in vivo growth hormone secretory events in man. Am. J. Physiol. 260:1991;E101-E110.
165. Hartman M.L., Pincus S.M., Johnson M.L., Matthews D.H., Faunt L.M., Vance M.L.et al. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J. Clin. Invest. 94:1994;1277-1288.
166. Hashida S., Ishikawa E., Kato Y., Imura H., Mohri Z., Murakami Y. Human growth hormone (hGH) in urine and its correlation to serum hGH examined by a highly sensitive sandwich enzyme immunoassay. Clin. Chim. Acta. 162:1987;229-235.
167. Hataya Y., Akamizu T., Takaya K., Kanamoto N., Ariyasu H., Saijo M.et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J. Clin. Endocrinol. Metab. 86:2001;4552.
168. Heald A., Selby P.L., White A., Gibson J.M. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis. Am. J. Obstet. Gynecol. 183:2000;593-600.
169. Heger S., Partsch C.J., Peter M., Blum W.F., Kiess W., Sippell W.G. Serum leptin levels in patients with progressive central precocious puberty. Pediatr. Res. 46:1999;71-75.
170. Heisler L.E., Pallotta C.M., Reid R.L., van Vugt D.A. Hypoglycemia-induced inhibition of luteinizing hormone secretion in the rhesus monkey is not mediated by endogenous opioid peptides. J. Clin. Endocrinol. Metab. 76:1993;1280-1285.
171. Helboe L., Stidsen C.E., Moller M. Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sst1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus. J. Neurosci. 18:1998;4938-4945.
172. Helmreich D.L., Cameron J.L. Suppression of LH secretion during food restriction in male rhesus monkeys (Macaca mulatta): failure of naloxone to restore normal pulsatility. Neuroendocrinology. 56:1992;464-473.
173. Hennen G., Frankenne F., Closset J., Gomez F., Pirens G. A human placental GH: increasing levels during second half of pregnancy and pituitary GH suppression as revealed by monoclonal antibody radioimmunoassay. Int. J. Fertil. 30:1985;27-34.
174. Henry B.A., Goding J.W., Tilbrook A.J., Dunshea F.R., Clarke I.J. Intracerebroventricular infusion of leptin elevates the secretion of luteinising hormone without affecting food intake in long-term food-restricted sheep, but increases growth hormone irrespective of bodyweight. J. Endocrinol. 168:2001;67-77.
175. Hess R.A., Bunick D., Lee K.H., Bahr J., Taylor J.A., Korach K.S.et al. A role for oestrogens in the male reproductive system. Nature. 390:1997;509-512.
176. Hesse V., Jahreis G., Schambach H., Vogel H., Vilser C., Seewald H.J.et al. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age. Exp. Clin. Endocrinol. 102:1994;289-298.
177. Hileman S.M., Lubbers L.S., Petersen S.L., Kuehl D.E., Scott C.J., Jackson G.L. Influence of testosterone on LHRH release, LHRH mRNA and proopiomelanocortin mRNA in male sheep. J. Neuroendocrinol. 8:1996;113-121.
178. Hindmarsh P.C., Dennison E., Pincus S.M., Cooper C., Fall C.H., Matthews D.R.et al. Sexually dimorphic pattern of growth hormone secretion in the elderly. J. Clin. Endocrinol. Metab. 84:1999;2679-2685.
179. Hiney J.K., Srivastava V., Nyberg C.L., Ojeda S.R., Dees W.L. Insulin-like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology. 137:1996;3717-3728.
180. Hizuka N., Takano K., Asakawa K., Sukegawa I., Fukuda I., Demura H.et al. Measurement of free form of insulin-like growth factor I in human plasma. Growth Regul. 1:1991;51-55.
181. Ho K.K., O'Sullivan A.J., Weissberger A.J., Kelly J.J. Sex steroid regulation of growth hormone secretion and action. Horm. Res. 45:1996;67-73.
182. Hobbs C.J., Plymate S.R., Rosen C.J., Adler R.A. Testosterone administration increases insulin-like growth factor-I levels in normal men. J. Clin. Endocrinol. Metab. 77:1993;776-779.
183. Holl R.W., Hartman M.L., Veldhuis J.D., Taylor W.M., Thorner M.O. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J. Clin. Endocrinol. Metab. 72:1991;854-861.
184. Holl R.W., Schwarz U., Schauwecker P., Benz R., Veldhuis J.D., Heinze E. Diurnal variation of the elimination of human growth hormone: the serum half-life is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol. J. Clin. Endocrinol. Metab. 77:1993;216-220.
185. Hompes P.G., Vermes I., Tilders F.J., Schoemaker J. In vitro release of LHRH from the hypothalamus of female rats during prepubertal development. Neuroendocrinology. 35:1982;8-12.
186. Honda K., Bailey A.R., Bull P.M., Macdonald L.P., Dickson S.L., Leng G. An electrophysiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the paraventricular nucleus. Neuroscience. 90:1999;875-883.
187. Horvath T.L., Diano S., van den Pol A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 19:1999;1072-1087.
188. Hosoda H., Kojima M., Matsuo H., Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J. Biol. Chem. 275:2000;21995-22000.
189. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I.et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:1996;974-977.
190. Huhn W.C., Hartman M.L., Pezzoli S.S., Thorner M.O. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. J. Clin. Endocrinol. Metab. 76:1993;1202-1208.
191. Huhtaniemi I., Jiang M., Nilsson C., Pettersson K. Mutations and polymorphisms in gonadotropin genes. Mol. Cell. Endocrinol. 151:1999;89-94.
192. Hymer W.C., Kraemer W.J., Nindl B.C., Marx J.O., Benson D.E., Welsch J.R.et al. Characteristics of circulating growth hormone in women after acute heavy resistance exercise. Am. J. Physiol. Endocrinol. Metab. 281:2001;E878-E887.
193. Ibanez L., DiMartino-Nardi J., Potau N., Saenger P. Premature adrenarche - normal variant or forerunner of adult disease? Endocr. Rev. 21:2000;671-696.
194. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat. Rev. Neurosci. 2:2001;551-560.
195. Iranmanesh A., Grisso B., Veldhuis J.D. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J. Clin. Endocrinol. Metab. 78:1994;526-535.
196. Iranmanesh A., Lizarralde G., Veldhuis J.D. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73:1991;1081-1088.
197. Iranmanesh A., South S., Liem A.Y., Clemmons D., Thorner M.O., Weltman A.et al. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth-hormone-releasing-hormone (GHRH) pulsatile infusion. Eur. J. Endocrinol. 139:1998;59-71.
198. Isgaard J., Carlsson L., Isaksson O.G., Jansson J.O. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases serum-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous infusion. Endocrinology. 123:1988;2605-2610.
199. Jaffe C.A., Ho P.J., DeMott-Friberg R., Bowers C.Y., Barkan A.L. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J. Clin. Endocrinol. Metab. 77:1993;1641-1647.
200. Jaffe C.A., Turgeon D.K., Friberg R.D., Watkins P.B., Barkan A.L. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin. J. Clin. Endocrinol. Metab. 80:1995;3321-3326.
201. Janssen Y.J., Frolich M., Deurenberg P., Roelfsema F. Serum leptin levels during recombinant human GH therapy in adults with GH deficiency. Eur. J. Endocrinol. 137:1997;650-654.
202. Jansson J.O., Eden S., Isaksson O.G. Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev. 6:1985;128-150.
203. Jansson J.O., Ekberg S., Isaksson O.G., Mode A., Gustafsson J.A. Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology. 117:1985;1881-1889.
204. Jung H., Carmel P., Schwartz M.S., Witkin J.W., Bentele K.H., Westphal M.et al. Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J. Clin. Endocrinol. Metab. 84:1999;4695-4701.
205. Juul A., Holm K., Kastrup K.W., Pedersen S.A., Michaelsen K.F., Scheike T.et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J. Clin. Endocrinol. Metab. 82:1997;2497-2502.
206. Kallo I., Butler J.A., Barkovics-Kallo M., Goubillon M.L., Coen C.W. Oestrogen receptor beta-immunoreactivity in gonadotropin releasing hormone-expressing neurones: regulation by oestrogen. J. Neuroendocrinol. 13:2001;741-748.
207. Kalra S.P. Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone releasing hormone discharge. Endocr. Rev. 5:1993;507-538.
208. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100.
209. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology. 141:2000;4797-4800.
210. Kamegai J., Wakabayashi I., Kineman R.D., Frohman L.A. Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats. J. Neuroendocrinol. 11:1999;299-306.
211. Kaplowitz P.B., Oberfield S.E. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics. 104:1999;936-941.
212. Karolczak M., Kuppers E., Beyer C. Developmental expression and regulation of aromatase- and 5 alpha-reductase type I mRNA in the male and female mouse hypothalamus. J. Neuroendocrinol. 10:1998;267-274.
213. Kasa-Vubu J.Z., Padmanabhan V., Kletter G.B., Brown M.B., Reiter E.O., Sizonenko P.C.et al. Serum bioactive luteinizing and follicle-stimulating hormone concentrations in girls increase during puberty. Pediatr. Res. 34:1993;829-833.
214. Keenan B.S., Richards G.E., Ponder S.W., Dallas J.S., Nagamani M., Smith E.R. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J. Clin. Endocrinol. Metab. 76:1993;996-1001.
215. Kelch R.P., Kaplan S.L., Ghumbach M.M. Suppression of urinary and plasma follicle-stimulating hormone by exogenous estrogens in prepubertal and pubertal children. J. Clin. Invest. 52:1973;1122-1128.
216. Kelijman M., Frohman L.A. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion. J. Clin. Endocrinol. Metab. 71:1990;157-163.
217. Kennedy A., Gettys T.W., Watson P., Wallace P., Ganaway E., Pan Q.et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J. Clin. Endocrinol. Metab. 82:1997;1293-1300.
218. Kerkhofs M., Van Cauter E., Van Onderbergen A., Caufriez A., Thorner M.O., Copinschi G. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am. J. Physiol. 264:1993;E594-E598.
219. Kineman R.D., Kamegai J., Frohman L.A. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Endocrinology. 140:1999;3581-3586.
220. Klinger B., Silbergeld A., Deghenghi R., Frenkel J., Laron Z. Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children. Eur. J. Endocrinol. 134:1996;716-719.
221. Koegler F.H., Grove K.L., Schiffmacher A., Smith M.S., Cameron J.L. Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology. 142:2001;2586-2592.
222. Kolaczynski J.W., Ohannesian J.P., Considine R.V., Marco C.C., Caro J.F. Response of leptin to short-term and prolonged overfeeding in humans. J. Clin. Endocrinol. Metab. 81:1996;4162-4165.
223. Komlos J. The age at menarche and age at first birth in an undernourished population. Ann. Hum. Biol. 16:1989;463-466.
224. Kratzsch J., Selisko T., Birkenmeier G. Identification of transformed alpha 2-macroglobulin as a growth hormone-binding protein in human blood. J. Clin. Endocrinol. Metab. 80:1995;585-590.
225. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F.et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. U.S.A. 95:1998;15677-15682.
226. Krsmanovic L.Z., Martinez-Fuentes A.J., Arora K.K., Mores N., Tomic M., Stojilkovic S.S.et al. Local regulation of gonadotroph function by pituitary gonadotropin-releasing hormone. Endocrinology. 141:2000;1187-1195.
227. Kulin H.E., Demers L.M., Rogol A.D., Veldhuis J.D. The effect of long-term opiate agonist administration to peripubertal boys. J. Androl. 8:1987;374-377.
228. Kulin H.E., Grumbach M.M., Kaplan S.L. Changing sensitivity of the pubertal gonadal hypothalamic feedback mechanism in man. Science. 166:1969;1012-1013.
229. Lado-Abeal J., Hickox J.R., Cheung T.L., Veldhuis J.D., Hardy D.M., Norman R.L. Neuroendocrine consequences of fasting in adult male macaques: effects of recombinant rhesus macaque leptin infusion. Neuroendocrinology. 71:2000;196-208.
230. Lado-Abeal J., Veldhuis J.D., Norma R.L. Glucose relays information regarding nutritional status to the neural circuits that control the somatotropic, corticotropic, and gonadotropic axes in adult male rhesus macaques. Endocrinology. 143:2002;403-410.
231. Lago F., Senaris R.M., Emson P.C., Dominguez F., Dieguez C. Evidence for the involvement of non-androgenic testicular factors in the regulation of hypothalamic somatostatin and GHRH mRNA levels. Brain Res. Mol. Brain Res. 35:1996;220-226.
232. Landefeld T.D., Ebling F.J., Suttie J.M., Vannerson L.A., Padmanabhan V., Beitins I.Z.et al. Metabolic interfaces between growth and reproduction. II. Characterization of changes in messenger ribonucleic acid concentrations of gonadotropin subunits, growth hormone, and prolactin in nutritionally growth-limited lambs and the differential effects of increased nutrition. Endocrinology. 125:1989;351-356.
233. Langendonk J.G., Pijl H., Schoemaker R., Burggraaf K., Cohen A., Veldhuis J.D.et al. Estimates of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach. Am. J. Physiol. 280:2001;R225-R232.
234. Laron Z., Bowers C.Y., Hirsch D., Almonte A.S., Pelz M., Keret R.et al. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Acta Endocrinol. 129:1993;424-425.
235. Laron Z., Frenkel J., Deghenghi R., Anin S., Klinger B., Silbergeld A. Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clin. Endocrinol. 43:1995;631-635.
236. Larsen P.J., Tang-Christensen M., Stidsen C.E., Madsen K., Smith M.S., Cameron J.L. Activation of central neuropeptide Y Y1 receptors potently stimulates food intake in male rhesus monkeys. J. Clin. Endocrinol. Metab. 84:1999;3781-3791.
237. Lasko C.M., Korytko A.I., Wehrenberg W.B., Cuttler L. Differential GH-releasing hormone regulation of GHRH receptor mRNA expression in the rat pituitary. Am. J. Physiol. Endocrinol. Metab. 280:2001;E626-E631.
238. Laursen T., Flyvbjerg A., Jorgensen J.O., Baxter R.C., Christiansen J.S. Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients. J. Clin. Endocrinol. Metab. 85:2000;4310-4314.
239. Laursen T., Gravholt C.H., Heickendorff L., Drustrup J., Kappelgaard A.M., Jorgensen J.O.et al. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. J. Clin. Endocrinol. Metab. 86:2001;1222-1228.
240. Le Romancer M., Reyl-Desmars F., Cherifi Y., Pigeon C., Bottari S., Meyer O.et al. The 86-kDa subunit of autoantigen Ku is a somatostatin receptor regulating protein phosphatase-2A activity. J. Biol. Chem. 269:1994;17464-17468.
241. Lebrethon M.C., Vandersmissen E., Gerard A., Parent A.S., Bourguignon J.P. Cocaine and amphetamine-regulated-transcript peptide mediation of leptin stimulatory effect on the rat gonadotropin-releasing hormone pulse generator in vitro. J. Neuroendocrinol. 12:2000;383-385.
242. Legraverend C., Mode A., Westin S., Strom A., Eguchi H., Zaphiropoulos P.G.et al. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol. 6:1992;259-266.
243. Lescheid D.W., Terasawa E., Abler L.A., Urbanski H.F., Warby C.M., Millar R.P.et al. A second form of gonadotropin-releasing hormone (GnRH) with characteristics of chicken GnRH-II is present in the primate brain. Endocrinology. 138:1997;5618-5629.
244. Levy L., Bourdais J., Mouhieddine B., Benlot C., Villares S., Cohen P.et al. Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas. J. Clin. Endocrinol. Metab. 76:1993;85-90.
245. Lewis U.J., Sinha Y.N., Lewis G.P. Structure and properties of members of the hGH family: a review. Endocr. J. 47(Suppl.):2000;1-8.
246. Li X.A., Warren D.W., Gregoire J., Pedersen R.C., Lee A.S. The rat 78,000 dalton glucose-regulated protein (GRP78) as a precursor for the rat steroidogenesis-activator polypeptide (SAP): the SAP coding sequence is homologous with the terminal end of GRP78. Mol. Endocrinol. 3:1989;1944-1952.
247. Licinio J., Mantzoros C., Negrao A.B., Cizza G., Wong M.L., Bongiorno P.B.et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature. 3:1997;575-579.
248. Licinio J., Negra A.B., Mantzoros C., Kaklamani V., Wong M.L., Bongiorno P.B.et al. Sex differences in circulating human leptin pulse amplitude: clinical implications. J. Clin. Endocrinol. Metab. 83:1998;4140-4147.
249. Liu L., Merriam G.R., Sherins R.J. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 64:1987;651-656.
250. Loche S., Colao A., Cappa M., Bellone J., Aimaretti G., Farello G.et al. The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J. Clin. Endocrinol. Metab. 82:1997;861-864.
251. Loche S, Faedda A, Colao A, Merola B, Lombardi G, Cappa M, et al. Reproducibility of the growth hormone response to hexarelin in children and the effect of sex steroids. In: Bercu BB, Walker RF, editors. Growth hormone secretagogues in clinical practice. New York: Marcel Dekker Inc.; 1998. p. 385-93.
252. Loesch D.Z., Hopper J.L., Rogucka E., Huggins R.M. Timing and genetic rapport between growth in skeletal maturity and height around puberty: similarities and differences between girls and boys. Am. J. Hum. Genet. 56:1995;753-759.
253. Lonnqvist F., Nordfors L., Jansson M., Thorne A., Schallling M., Arner P. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J. Clin. Invest. 99:1997;2398-2404.
254. Luna A.M., Wilson D.M., Wibbelsman C.J., Brown R.C., Nagashima R.J., Hintz R.L.et al. Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J. Clin. Endocrinol. Metab. 57:1983;268-271.
255. Maccario M., Aimaretti G., Corneli G., Gauna C., Grottoli S., Bidlingmaier M.et al. Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans. Am. J. Physiol. Endocrinol. Metab. 279:2000;E411-E416.
256. MacConnie S.E., Barkan A.L., Lampman R.M., Schork M.A., Beitins I.Z. Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. New Engl. J. Med. 315:1986;411-417.
257. Maeda K., Tsukamura H. Neuroendocrine mechanism mediating fasting-induced suppression of luteinizing hormone secretion in female rats. Acta Neurobiol. Exp. 56:1996;787-796.
258. Magni P., Vettor R., Pagano C., Calcagno A., Beretta E., Messi E.et al. Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons. Endocrinology. 140:1999;1581-1585.
259. Malhotra A., Poon E., Tse W.Y., Pringle P.J., Hindmarsh P.C., Brook C.G. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. Clin. Endocrinol. 38:1993;393-398.
260. Mantzoros C.S., Qu D., Frederich R.C., Susulic V.S., Lowell B.B., Maratos-Flier E.et al. Activation of β3-adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 45:1996;909-914.
261. Marin G., Domene H.M., Barnes K.M., Blackwell B.J., Cassorla F.G., Cutler G.B. Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J. Clin. Endocrinol. Metab. 79:1994;537-541.
262. Martha P.M. Jr., Goorman K.M., Blizzard R.M., Rogol A.D., Veldhuis J.D. Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: relationship to age, pubertal status and body mass. J. Clin. Endocrinol. Metab. 74:1992;336-344.
263. Martha P.M. Jr., Rogol A.D., Veldhuis J.D., Blizzard R.M. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. The neuroendocrine growth hormone axis during late prepuberty. J. Clin. Endocrinol. Metab. 81:1996;4068-4074.
264. Martha P.M. Jr., Rogol A.D., Veldhuis J.D., Kerrigan J.R., Goodman D.W., Blizzard R.M. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J. Clin. Endocrinol. Metab. 69:1989;563-570.
265. Marzullo P., Di Somma C., Pratt K.L., Khosravi J., Diamandis A., Lombardi G.et al. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J. Clin. Endocrinol. Metab. 86:2001;3001-3008.
266. Matkovic V., Ilich J.Z., Skugor M., Badenhop N.E., Goel P., Clairmont A.et al. Leptin is inversely related to age at menarche in human females. J. Clin. Endocrinol. Metab. 82:1997;3239-3245.
267. Mauras N., Rogol A.D., Haymond M.W., Veldhuis J.D. Sex steroids, growth hormone, IGF-I: neuroendocrine and metabolic regulation in puberty. Horm. Res. 45:1996;74-80.
268. Mauras N., Rogol A.D., Veldhuis J.D. Appraising the instantaneous secretory rates of luteinizing hormone and testosterone in response to selective mu opiate receptor blockade in late pubertal boys. J. Androl. 8:1987;201-207.
269. Mauras N., Walton P., Nicar M., Welch S., Rogol A.D. Growth hormone stimulation testing in both short and normal statured children: use of an immunofunctional assay. Pediatr. Res. 48:2000;614-618.
270. Mayo K.E., Miller T., DeAlmeida V., Godfrey P., Zheng J., Cunha S.R. Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent Prog. Horm. Res. 55:2000;237-266.
271. McCarthy M.M., Davis A.M., Mong J.A. Excitatory neurotransmission and sexual differentiation of the brain. Brain Res. Bull. 44:1997;487-495.
272. Mercer J.G., Hoggard N., Williams L.M. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J. Neuroendocrinol. 8:1996;733-735.
273. Mericq V., Cassorla F., Salazar T., Avila A., Iniguez G., Bowers C.Y.et al. Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J. Clin. Endocrinol. Metab. 83:1998;2355-2360.
274. Meyer J.M., Eaves L.J., Heath A.C., Martin N.G. Estimating genetic influences on the age-at-menarche: a survival analysis approach. Am. J. Med. Genet. 39:1991;148-154.
275. Mitsugi N., Arita J., Kimura F. Effects of intracerebroventricular administration of growth hormone-releasing factor and corticotropin-releasing factor on somatostatin secretion into rat hypophysial portal blood. Neuroendocrinology. 51:1990;93-96.
276. Mode A., Norstedt G., Simic B., Eneroth P., Gustafsson J.A. Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology. 103:1981;2103-2108.
277. Mode A., Wiersma-Larsson E., Strom A., Zaphiropoulos P.G., Gustafsson J.A. A dual role of growth hormone as a feminizing and masculinizing factor in the control of sex-specific cytochrome P450 isozymes in rat liver. J. Endocrinol. 120:1989;311-317.
278. Moller J., Jorgensen J.O., Lauersen T., Frystyk J., Naeraa R.W., Orskov H.et al. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin. Endocrinol. 39:1993;403-408.
279. Moller N., Jorgensen J.O., Schmitz O., Moller J., Christiansen J., Alberti K.G.et al. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am. J. Physiol. 258:1990;E86-E91.
280. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J.et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
281. Montero M., Yon L., Kikuyama S., Dufour S., Vaudry H. Molecular evolution of the growth hormone-releasing hormone/pituitary adenylate cyclase-activating polypeptide gene family. Functional implication in the regulation of growth hormone secretion. J. Mol. Endocrinol. 25:2000;157-168.
282. Morash B., Li A., Murphy P.R., Wilkinson M., Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology. 140:1999;5995-5998.
283. Mueller E.E., Locatelli V., Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 79:1999;511-607.
284. Mulligan T., Iranmanesh A., Kerzner R., Demers L.W., Veldhuis J.D. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig-cell) defects in the healthy aging male gonadotropic axis. Eur. J. Endocrinol. 141:1999;257-266.
285. Murahashi K., Bucholtz D.C., Nagatani S., Tsukahara S., Tsukamura H., Foster D.L.et al. Suppression of luteinizing hormone pulses by restriction of glucose availability is mediated by sensors in the brain stem. Endocrinology. 137:1996;1171-1176.
286. Murphy L.J., Freisen H.G. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor-I expression in the ovariectomized hypophysectomised rat. Endocrinology. 122:1988;325-332.
287. Nagatani S., Guthikonda P., Thompson R.C., Tsukamura H., Maeda K.I., Foster D.L. Evidence for GnRH regulation by leptin: leptin administration prevents reduced pulsatile LH secretion during fasting. Neuroendocrinology. 67:1998;370-376.
288. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K.et al. A role for ghrelin in the central regulation of feeding. Nature. 409:2001;194-198.
289. Nazian S.J. Development and control of the opioid inhibition of gonadotropin secretion during the sexual maturation of the male rat. Neuroendocrinology. 55:1992;613-620.
290. Neill J.D. GnRH and GnRH receptor genes in the human genome. Endocrinology. 143:2002;737-743.
291. Nielsen S., Mellemkjaer S., Rasmussen L.M., Ledet T., Astrup J., Weeke J.et al. Gene transcription of receptors for growth hormone-releasing peptide and somatostatin in human pituitary adenomas. J. Clin. Endocrinol. Metab. 83:1998;2997-3000.
292. Nurhidayat J., Tsukamoto Y., Sasaki F. Role of the gonads in sex differentiation of growth hormone-releasing hormone and somatostatin neurons in the mouse hypothalamus during postnatal development. Brain Res. 890:2001;154-161.
293. Obal F. Jr., Fang J., Taishi P., Kacsoh B., Gardi J., Krueger J.M. Deficiency of growth hormone-releasing hormone signaling is associated with sleep alterations in the dwarf rat. J. Neurosci. 21:2001;2912-2918.
294. 2+ elevating to depressing. J. Neurosci. 15:1995;5065-5077.
295. Ogawa S., Chan J., Chester A.E., Gustafsson J.A., Korach K.S., Pfaff D.W. Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12887-12892.
296. Ogawa S., Washburn T.F., Taylor J., Lubahn D.B., Korach K.S., Pfaff D.W. Modifications of testosterone-dependent behaviors by estrogen receptor-alpha gene disruption in male mice. Endocrinology. 139:1998;5058-5069.
297. Ohkura S., Tanaka T., Nagatani S., Bucholtz D.C., Tsukamura H., Maeda K.et al. Central, but not peripheral, glucose-sensing mechanisms mediate glucoprivic suppression of pulsatile luteinizing hormone secretion in the sheep. Endocrinology. 141:2000;4472-4480.
298. Oleksik A.M., Duong T., Pliester N., Asma G., Popp-Snijders C., Lips P. Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis. J. Clin. Endocrinol. Metab. 86:2001;2763-2768.
299. Ovesen P., Vahl N., Fisker S., Veldhuis J.D., Christiansen J.S., Jorgensen J.O. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the preovulatory interval in normal women. J. Clin. Endocrinol. Metab. 83:1998;1662-1667.
300. Painson J.C., Veldhuis J.D., Tannenbaum G.S. Single exposure to testosterone in adulthood rapidly induces regularity in the growth hormone release process. Am. J. Physiol. 278:2000;E933-E940.
301. Palmert M.R., Radovick S., Boepple P.A. The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. J. Clin. Endocrinol. Metab. 83:1998;1091-1096.
302. Parenti M., Cocchi D., Ceresoli G., Marcozzi C., Mueller E.E. Age-related changes of growth hormone secretory mechanism in the rat pituitary gland. J. Endocrinol. 131:1991;251-256.
303. Park S.H., Liu X., Hennighausen L., Davey H.W., Waxman D.J. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J. Biol. Chem. 274:1999;7421-7430.
304. Pelletier G., Labrie C., Labrie F. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. J. Endocrinol. 165:2000;359-370.
305. Penny R., Olambiwonnu N.O., Frasier S.D. Episodic fluctuations of serum gonadotropins in pre- and post-pubertal girls and boys. J. Clin. Endocrinol. Metab. 45:1977;307-311.
306. Petersen S.L., McCrone S., Keller M., Gardner E. Rapid increase in LHRH mRNA levels following NMDA. Endocrinology. 129:1991;1679-1681.
307. Petraglia F., Bernasconi S., Lughetti L., Loche S. Naloxone induced LH secretion in normal precocious, and delayed puberty. J. Clin. Endocrinol. Metab. 63:1986;1112-1116.
308. Pihoker C., Badger T.M., Reynolds G.A., Bowers C.Y. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J. Endocrinol. 155:1997;79-86.
309. Pijl H., Langendonk J.G., Burggraaf J., Frolich M., Cohen A.F., Veldhuis J.D.et al. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J. Clin. Endocrinol. Metab. 86:2001;5509-5515.
310. Pincus S.M. Approximate entropy as a measure of system complexity. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2297-2301.
311. Pincus S.M. Greater signal regularity may indicate increased system isolation. Math. Biosci. 122:1994;161-181.
312. Pincus S.M., Gevers E., Robinson I.C., van den Berg G., Roelfsema F., Hartman M.L.et al. Females secrete growth hormone with more process irregularity than males in both human and rat. Am. J. Physiol. 270:1996;E107-E115.
313. Pincus S.M., Hartman M.L., Roelfsema F., Thorner M.O., Veldhuis J.D. Hormone pulsatility discrimination via coarse and short time sampling. Am. J. Physiol. 277:1999;E948-E957.
314. Pincus S.M., Mulligan T., Iranmanesh A., Gheorghiu S., Godschalk M., Veldhuis J.D. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14100-14105.
315. Pincus S.M., Veldhuis J.D., Rogol A.D. Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys. Am. J. Physiol. Endocrinol. Metab. 279:2000;E417-E424.
316. Ping L., Mahesh V.B., Brann D.W. Effect of NMDA and non-NMDA receptor antagonists on pulsatile luteinizing hormone secretion in the adult male rat. Neuroendocrinology. 61:1995;226-234.
317. Pinilla L., Gonzalez L.C., Tena-Sempere M., Aguilar E. Cross-talk between excitatory and inhibitory amino acids in the regulation of growth hormone secretion in neonatal rats. Neuroendocrinology. 73:2001;62-67.
318. Plant T.M., Gay V.L., Marshall G.R., Arslan M. Puberty in monkeys is triggered by chemical stimulation of the hypothalamus. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2506-2510.
319. Plotsky P.M., Vale W.W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science. 230:1985;461-463.
320. Pombo M., Leal-Cerro A., Barreiro J., Penalva A., Peino R., Mallo F.et al. Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency. J. Pediatr. Endocrinol. Metab. 3:1996;333-338.
321. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F.F. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergistic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J. Clin. Endocrinol. Metab. 80:1995;942-947.
322. Porquet D., Rigal O., Brion D.E., Valade F., Leger J., Czernichow P. Direct double monoclonal immunoradiometric assay of urinary human growth hormone. Clin. Chem. 38:1992;1717-1721.
323. Prank K., Kloppstech M., Nowlan S.J., Sejnowski T.J., Brabant G. Self-organized segmentation of time series: separating growth hormone secretion in acromegaly from normal controls. Biophys. J. 70:1996;2540-2547.
324. Quinton N.D., Smith R.F., Clayton P.E., Gill M.S., Shalet S., Justice S.K.et al. Leptin binding activity changes with age: the link between leptin and puberty. J. Clin. Endocrinol. Metab. 84:1999;2336-2341.
325. Radetti G., Bozzola M., Pagani S., Avanzini M.A., Messner H., Belloni C.et al. Circulating GH isoforms and GH bioactivity in preterm neonates. Pediatr. Res. 48:2000;244-247.
326. Rage F., Hill D.F., Sena-Esteves M., Breakefield X.O., Coffey R.J., Costa M.E.et al. Targeting transforming growth factor alpha expression to discrete loci of the neuroendocrine brain induces female sexual precocity. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2735-2740.
327. Rakover Y., Lavi I., Masalah R., Issam T., Weiner E., Ben-Shlomo I. Comparison between four immunoassays for growth hormone (GH) measurement as guides to clinical decisions following GH provocative tests. J. Pediatr. Endocrinol. 13:2000;637-643.
328. Ralph M.R., Foster R.G., Davis F.C., Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science. 247:1990;975-978.
329. Ramirez V.D., Zheng J. Membrane sex-steroid receptors in the brain. Front. Neuroendocrinol. 17:1996;402-439.
330. Rapisarda J.J., Bergman K.S., Steiner R.A., Foster D.L. Response to estradiol inhibition of tonic luteinizing hormone secretion decreases during the final stage of puberty in the rhesus monkey. Endocrinology. 112:1983;1172-1179.
331. Rauly I., Saint-Laurent N., Delesque N., Buscail L., Esteve J.P., Vaysse N.et al. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells. J. Clin. Invest. 97:1996;1874-1883.
332. Reichlin S. Growth and the hypothalamus. Endocrinology. 67:1960;760-773.
333. Reutens A.T., Hoffman D.M., Leung K.C., Ho K.K. Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency. J. Clin. Endocrinol. Metab. 80:1995;480-485.
334. Reutens A.T., Veldhuis J.D., Hoffman D.M., Leung K.C., Ho K.K. A highly sensitive growth hormone (GH) ELISA uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency. J. Clin. Endocrinol. Metab. 81:1996;1591-1597.
335. Rhoda J., Corbier P., Roffi J. Gonadal steroid concentrations in serum and hypothalamus of the rat at birth: aromatization of testosterone to 17 beta-estradiol. Endocrinology. 114:1984;1754-1760.
336. Richmond E., Rogol A.D., Basdemir D., Veldhuis O.L., Clarke W., Bowers C.Y.et al. Accelerated escape from growth-hormone (GH) autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys. J. Clin. Endocrinol. Metab. 87:2002;3837-3844.
337. Robinson I.C. The growth hormone secretory pattern: response to neuroendocrine signals. Acta Paediatr. Scand. (Suppl.). 372:1991;70-78.
338. Roelfsema F., Biermasz N.R., Veldman R.G., Veldhuis J.D., Frolich M., Stokvis-Brantsma W.H.et al. Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J. Clin. Endocrinol. Metab. 86:2000;2459-2464.
339. Roemmich J.N., Clark P.A., Berr S.S., Mai V., Mantzoros C.S., Flier J.S.et al. Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. Am. J. Physiol. 275:1998;E543-E551.
340. Roemmich J.N., Clark P.A., Mai V., Berr S.S., Weltman A., Veldhuis J.D.et al. Alterations in growth and body composition during puberty. III. Influence of maturation, gender, body composition, fat distribution, aerobic fitness, and energy expenditure on nocturnal growth hormone release. J. Clin. Endocrinol. Metab. 83:1998;1440-1447.
341. Rogers K.V., Vician L., Steiner R.A., Clifton D.K. The effect of hypophysectomy and growth hormone administration on pre-prosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus. Endocrinology. 122:1988;586-591.
342. Rosenfield R.L., Furlanetto R. Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin. J. Pediatr. 107:1985;415-417.
343. Roth J., Glick S.M., Yalow R.S., Berson S.A. A potent stimulus to secretion of growth hormone. Science. 140:1963;987-989.
344. Roy D., Angelini N.L., Belsham D.D. Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons. Endocrinology. 140:1999;5045-5053.
345. Rudling M., Norstedt G., Olivecrona H., Reihner E., Gustafsson J.A., Angelin B. Importance of growth hormone for the function of hepatic low density lipoprotein receptors. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6983-6987.
346. Ruiz-Cortes Z.T., Men T., Palin M.F., Downey B.R., Lacroix D.A., Murphy B.D. Porcine leptin receptor: molecular structure and expression in the ovary. Mol. Reprod. Dev. 56:2000;465-474.
347. Samson W.K., Taylor M.M. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:2001;R1140-R1145.
348. Satozawa N., Takezawa K., Miwa T., Takahashi S., Hayakawa M., Ooka H. Differences in the effects of 20 K- and 22 K-hGH on water retention in rats. Growth Horm. IGF Res. 10:2000;187-192.
349. Saunders A., Terry L.C., Audet J., Brazeau P., Martin J.B. Dynamic studies of growth hormone and prolactin secretion in the female rat. Neuroendocrinology. 21:1976;193-203.
350. Sawchenko P.E. Toward a new neurobiology of energy balance, appetite, and obesity: the anatomists weigh in. J. Comp. Neurol. 402:1998;435-441.
351. Schaefer F., Baumann G., Faunt L.M., Haffner D., Johnson M.L., Mercado M.et al. Multifactorial control of the elimination kinetics of unbound (free) GH in the human: regulation by age, adiposity, renal function, and steady-state concentrations of GH in plasma. J. Clin. Endocrinol. Metab. 81:1996;22-31.
352. Schanbacher B.D. Effects of intermittent pulsatile infusion of luteinizing hormone-releasing hormone on dihydrotestosterone-suppressed gonadotropin secretion in castrate rams. Biol. Reprod. 33:1985;603-611.
353. Schindler M., Humphrey P.P., Emson P.C. Somatostatin receptors in the central nervous system. Prog. Neurobiol. 50:1996;9-47.
354. Schneider J.E., Zhu Y. Caudal brain stem plays a role in metabolic control of estrous cycles in Syrian hamsters. Brain Res. 661:1994;70-74.
355. Schoeller D.A., Cella L.K., Sinha M.K., Crao J.F. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J. Clin. Invest. 100:1997;1882-1887.
356. Schubring C., Kiess W., Englaro P., Rascher W., Dotsch J., Hanitsch S.et al. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J. Clin. Endocrinol. Metab. 82:1997;1480-1483.
357. Schwartz I.D., Grunt J.A., Berg S., Jacobson J.D., Moore W.V., Howard C.P. Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction. J. Pediatr. Endocrinol. 13:2000;645-650.
358. Schwartz M.W., Seeley R.J. Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. New Engl. J. Med. 336:1997;1802-1811.
359. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
360. Sealfon S.C., Weinstein H., Millar R.P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr. Rev. 18:1997;180-205.
361. Shah N., Aloi J., Evans W.S., Veldhuis J.D. Time-mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations rather than sex, estradiol, or menstrual-cycle stage primarily determine the GH elimination rate in healthy young women and men. J. Clin. Endocrinol. Metab. 84:1999;2862-2869.
362. Shah N., Evans W.S., Bowers C.Y., Veldhuis J.D. Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-h GH-releasing peptide (GHRP-2) infusion: pulsatile, entropic, and nyctohemeral mechanisms. J. Clin. Endocrinol. Metab. 84:1999;2140-2150.
363. Shah N., Evans W.S., Bowers C.Y., Veldhuis J.D. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2 driven GH secretion in postmenopausal women. J. Clin. Endocrinol. Metab. 85:2000;2649-2659.
364. Shah N., Evans W.S., Veldhuis J.D. Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am. J. Physiol. 276:1999;R1351-R1358.
365. Shimon I., Yan X., Taylor J.E., Weiss M.H., Culler M.D., Melmed S. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. J. Clin. Invest. 100:1997;2386-2392.
366. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K.et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 50:2001;227-232.
367. Skynner M.J., Sim J.A., Herbison A.E. Detection of estrogen receptor alpha and beta messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology. 140:1999;5195-5201.
368. 125I -somatostatin-labeled cells in the anterior arcuate nucleus mediate somatostatin effects on growth hormone but not prolactin secretion Neuroendocrinology. 58:1993;178-184.
369. Slama A., Videau C., Kordon C., Epelbaum J. Estradiol regulation of somatostatin receptors in the arcuate nucleus of the female rat. Neuroendocrinology. 56:1992;240-245.
370. Smals A.E., Pieters G.F., Smals A.G., Benraad T.J., Kloppenborg P.W. Sex difference in growth hormone response to growth hormone-releasing hormone between pubertal tall girls and boys. Acta Endocrinol. 116:1987;161-164.
371. Smals A.E., Pieters G.F., Smals A.G., Benraad T.J., van Laarhoven J., Kloppenborg P.W. Sex difference in human growth hormone (GH) response to intravenous human pancreatic GH-releasing hormone administration in young adults. J. Clin. Endocrinol. Metab. 62:1986;336-341.
372. Smith M.J., Jiennes L., Wise P.M. Localization of the VIP2 receptor protein on GnRH neurons in the female rat. Endocrinology. 141:2000;4317-4320.
373. Smith P.L., Kaettzel D., Nilson J.H., Baenziger J.U. The sialylated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity. J. Biol. Chem. 265:1990;874-881.
374. Smith R.G., Griffin P.R., Xu Y., Smith A.G., Liu K., Calacay J.et al. Adenosine: a partial agonist of the growth hormone secretagogue receptor. Biochem. Biophys. Res. Commun. 276:2000;1306-1313.
375. Smith R.G., Leonard R., Bailey A.R., Palyha O., Feighner S., Tan C.et al. Growth hormone secretagogue receptor family members and ligands. Endocrine. 14:2001;9-14.
376. Smith S.R., Bledsoe T., Chhetri M.K. Cortisol metabolism and the pituitary-adrenal axis in adults with protein-calorie malnutrition. J. Clin. Endocrinol. Metab. 40:1975;43-52.
377. Soldani R., Cagnacci A., Yen S.S. Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur. J. Endocrinol. 131:1994;641-645.
378. Soya H., Suzuki M. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro. Endocrinology. 122:1988;2492-2498.
379. Spellacy W.N., Buhi W.C. Pituitary GH and PL levels measured in normal term pregnancy and at the early and late postpartum periods. Am. J. Obstet. Gynecol. 15:1969;888-896.
380. Spijkstra J.J., Spinder T., Gooren L., van Kessel H. Divergent effects of the antiestrogen tamoxifen and of estrogens on luteinizing hormone (LH) pulse frequency, but not on basal LH levels and LH pulse amplitude in men. J. Clin. Endocrinol. Metab. 66:1988;355-360.
381. Spinder T., Spijkstra J.J., van den Tweel J.G., Burger C.W., van Kessel H., Hompes P.G.et al. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J. Clin. Endocrinol. Metab. 69:1989;151-157.
382. Stachura M.E., Tyler J.M., Farmer P.K. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion. Endocrinology. 123:1988;1476-1482.
383. Stanhope R., Pringle P.J., Brook C.G. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue. Acta Paediatr. Scand. 77:1988;525-530.
384. Straume M., Johnson M.L., Veldhuis J.D. Statistically accurate estimation of hormone concentrations and associated uncertainties: methodology, validation, and applications. Clin. Chem. 44:1998;116-123.
385. Straume M., Veldhuis J.D., Johnson M.L. Model-independent quantification of measurement error: empirical estimation of discrete variance function profiles based on standard curves. Methods Enzymol. 240:1994;121-150.
386. Strobel A., Issad T., Camoin L., Ozata M., Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18:1998;213-215.
387. Suter K.J., Pohl C.R., Wilson M.E. Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys: potential signals for the initiation of puberty. J. Clin. Endocrinol. Metab. 85:2000;808-814.
388. Szabo M., Butz M.R., Banerjee S.A., Chikaraaishi D.M., Frohman L.A. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus. Endocrinology. 136:1995;4044-4048.
389. Tanaka T., Shiu R.P., Gout P.W., Beer C.T., Noble R.L., Friesen H.G. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J. Clin. Endocrinol. Metab. 51:1980;1058-1063.
390. Tannenbaum G.S., Choi H.K., Gurd W., Waxman D.J. Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology. 142:2001;4599-4606.
391. Tannenbaum G.S., Gurd W., Lapointe M. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology. 139:1998;3871-3875.
392. Tannenbaum G.S., Zhang W.H., Lapointe M., Zeitler P., Beaudet A. Growth hormone-releasing hormone neurons in the arcuate nucleus express both Sst1 and Sst2 somatostatin receptor genes. Endocrinology. 139:1998;1450-1453.
393. Terasawa E., Fernandez D.L. Neurobiological mechanisms of the onset of puberty in primates. Endocr. Rev. 22:2001;111-151.
394. Thompson R.G., Rodriguez A., Kowarski A.A., Migeon C.J., Blizzard R.M. Integrated concentrations of growth hormone correlated with plasma testosterone and bone age in preadolescent and adolescent males. J. Clin. Endocrinol. Metab. 62:1978;1341-1344.
395. Thorner M., Rochiccioli P., Colle M., Lanes R., Grunt J., Galazka A.et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J. Clin. Endocrinol. Metab. 81:1996;1189-1196.
396. Thorner M.O., Rogol A.D., Blizzard R.M. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone. Pediatr. Res. 24:1988;145-151.
397. Thorner M.O., Vance M.L., Hartman M.L., Holl R.W., Evans W.S., Veldhuis J.D.et al. Physiological role of somatostatin on growth hormone regulation in humans. Metabolism. 39:1990;40-42.
398. Thorner M.O., Vance M.L., Rogol A.D., Blizzard R.M., Veldhuis J.D., Cauter E.V.et al. Growth hormone-releasing hormone and growth hormone-releasing peptide as potential therapeutic modalities. Acta Paediatr. Scand. (Suppl.). 367:1990;29-32.
399. Thornton J.E., Cheung C.C., Clifton D.K., Steiner R.A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology. 138:1997;5063-5066.
400. Tilemans D., Andries M., Denef C. Luteinizing hormone-releasing hormone and neuropeptide Y influence deoxyribonucleic acid replication in three anterior pituitary cell types. Evidence for mediation by growth factors released from gonadotrophs. Endocrinology. 130:1992;882-894.
401. Toppila J., Alanko L., Asikainen M., Tobler I., Stenberg D., Porkka-Heiskanen T. Sleep deprivation increases somatostatin and growth hormone-releasing hormone messenger RNA in the rat hypothalamus. Neurosci. Lett. 220:1997;97-100.
402. Tsukamura H., Nagatani S., Cagampang F.R., Kawakami S., Maeda K. Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of alpha-adrenergic receptors in the paraventricular nucleus in female rats. Endocrinology. 134:1994;1460-1466.
403. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A.et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7239-7244.
404. Urban R.J., Evans W.S., Rogol A.D., Kaiser D.L., Johnson M.L., Veldhuis J.D. Contemporary aspects of discrete peak detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr. Rev. 9:1988;3-37.
405. Urbanski H.F., Ojeda S.R. Activation of luteinizing hormone-releasing hormone release advances the onset of female puberty. Neuroendocrinology. 46:1987;273-276.
406. Van Cauter E., Caufriez A., Kerkhofs M., Van Onderbergen A., Thorner M.O., Copinschi G. Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 74:1992;1451-1459.
407. Van Cauter E., Kerkhofs M., Caufriez A., Van Onderbergen A., Thorner M.O., Copinschi G. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J. Clin. Endocrinol. Metab. 74:1992;1441-1450.
408. Van den Berg G., Frolich M., Veldhuis J.D., Roelfsema F. Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for down-regulation of the adrenal glands. J. Clin. Endocrinol. Metab. 80:1996;3750-3756.
409. Van den Berg G., Veldhuis J.D., Frolich M., Roelfsema F. An amplitude-specific divergence in the pulsatile mode of GH secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J. Clin. Endocrinol. Metab. 81:1996;2460-2466.
410. Van den Berghe G., Wouters P., Carlsson L., Baxter R.C., Bouillon R., Bowers C.Y. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83:1998;3062-3070.
411. Van der Werff ten Bosch J.J., Bot A. Growth of males with idiopathic hypopituitarism without growth hormone treatment. Clin. Endocrinol. 32:1990;707-717.
412. Van Kesteren P., Lips P., Deville W., Popp-Snijders C., Asscheman H., Megens J.et al. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J. Clin. Endocrinol. Metab. 81:1996;2227-2232.
413. Vance M.L., Kaiser D.L., Evans W.S., Furlanetto R., Vale W.W., Rivier J.et al. Pulsatile growth hormone secretion in normal man during a continuous 24-h infusion of human growth hormone releasing factor (1-40). J. Clin. Invest. 75:1985;1584-1590.
414. Veldhuis J.D. Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur. J. Endocrinol. 134:1996;287-295.
415. Veldhuis J.D. Neuroendocrine control of pulsatile growth-hormone release in the human: relationship with gender. Growth Horm. IGF Res. 8:1998;49-59.
416. Veldhuis JD. Male hypothalamic-pituitary-gonadal axis. In: Lipshultz LI, editor. Infertility in the male. 3rd ed. St. Louis: Mosby-Year Book; 1997. p. 23-58.
417. Veldhuis J.D., Anderson S.M., Shah N., Bray M., Vick T., Gentili A.et al. Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human. Growth Horm. IGF Res. 11:2001;S25-S37.
418. Veldhuis J.D., Carlson M.L., Johnson M.L. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7686-7690.
419. Veldhuis J.D., Evans W.S., Bowers C.Y. Impact of estradiol supplementation on dual peptidyl drive of growth-hormone secretion in postmenopausal women. J. Clin. Endocrinol. Metab. 87:2002;859-866.
420. Veldhuis J.D., Evans W.S., Johnson M.L. Complicating effects of highly correlated model variables on nonlinear least-squares estimates of unique parameter values and their statistical confidence intervals: estimating basal secretion and neurohormone half-life by deconvolution analysis. Methods Neurosci. 28:1995;130-138.
421. Veldhuis JD, Evans WS, Shah N, Story S, Bray MJ, Anderson SM. Proposed mechanisms of sex-steroid hormone neuromodulation of the human GH-IGF-I axis. In: Veldhuis JD, Giustina A, editors. Sex-steroid interactions with growth hormone. 1st ed. Part I. New York: Springer-Verlag; 1999. p. 93-121.
422. Veldhuis J.D., Faunt L.M., Johnson M.L. Analysis of nonequilibrium dynamics of bound, free, and total plasma ligand concentrations over time following nonlinear secretory inputs: evaluation of the kinetics of two or more hormones pulsed into compartments containing multiple variable-affinity binding proteins. Methods Enzymol. 240:1994;349-377.
423. Veldhuis J.D., Iranmanesh A., Evans W.S., Lizarralde G., Thorner M.O., Vance M.L. Amplitude suppression of the pulsatile mode of immunoradiometric LH release in fasting-induced hypoandrogenemia in normal men. J. Clin. Endocrinol. Metab. 76:1993;587-593.
424. Veldhuis J.D., Iranmanesh A., Samojlik E., Urban R.J. Differential sex-steroid negative feedback regulation of pulsatile follicle-stimulating hormone secretion in healthy older men: deconvolution analysis and steady state sex steroid hormone infusions in frequently sampled healthy older individuals. J. Clin. Endocrinol. Metab. 82:1997;1248-1254.
425. Veldhuis J.D., Johnson M.L. Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am. J. Physiol. 250:1986;E486-E493.
426. Veldhuis J.D., Johnson M.L. Deconvolution analysis of hormone data. Methods Enzymol. 210:1992;539-575.
427. Veldhuis J.D., Johnson M.L. Testing pulse detection algorithms with simulations of episodically pulsatile substrate, metabolite, or hormone release. Methods Enzymol. 240:1994;377-415.
428. Veldhuis J.D., Johnson M.L. Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data. Methods Neurosci. 28:1995;25-92.
429. Veldhuis J.D., Johnson M.L., Faunt L.M., Mercado M., Baumann G. Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. J. Clin. Invest. 91:1993;629-641.
430. Veldhuis J.D., Kulin H.E., Warner B.A., Santner S.J. Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals. J. Clin. Endocrinol. Metab. 55:1982;649-653.
431. Veldhuis J.D., Lassiter A.B., Johnson M.L. Operating behavior of dual or multiple endocrine pulse generators. Am. J. Physiol. 259:1990;E351-E361.
432. Veldhuis J.D., Liem A.Y., South S., Weltman A., Weltman J., Clemmons D.A.et al. Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J. Clin. Endocrinol. Metab. 80:1995;3209-3222.
433. Veldhuis J.D., Metzger D.L., Martha P.M. Jr., Mauras N., Kerrigan J.R., Keenan B.et al. Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J. Clin. Endocrinol. Metab. 82:1997;3414-3420.
434. Veldhuis J.D., Pincus S.M. Orderliness of hormone release patterns: a complementary measure to conventional pulsatile and circadian analyses. Eur. J. Endocrinol. 138:1998;358-362.
435. Veldhuis J.D., Roemmich J.N., Rogol A.D. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth-hormone (GH) secretion in prepubertal and late adolescent males and females. J. Clin. Endocrinol. Metab. 85:2000;2385-2394.
436. Veldhuis J.D., Rogol A.D., Perez-Palacios G., Stumpf P., Kitchin J.D., Dufau M.L. Endogenous opiates participate in the regulation of pulsatile LH release in an unopposed estrogen milieu: studies in estrogen-replaced, gonadectomized patients with testicular feminization. J. Clin. Endocrinol. Metab. 61:1985;790-793.
437. Veldhuis J.D., Straume M., Iranmanesh A., Mulligan T., Jaffe C.A., Barkan A.et al. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am. J. Physiol. 280:2001;R721-R729.
438. Veldhuis J.D., Urban R.J., Dufau M.L. Differential responses of biologically active LH secretion in older versus young men to interruption of androgen negative feedback. J. Clin. Endocrinol. Metab. 79:1994;1763-1770.
439. Veldhuis JD, Yoshida K, Iranmanesh A. The effect of mental and metabolic stress on the female reproductive system and female reproductive hormones. In: Hubbard JR, Workman EA, editors. Handbook of stress medicine: an organ system approach. Boca Raton, FL: CRC Press; 1997. p. 115-40.
440. Venables J.P., Cooke H.J. Lessons from knockout and transgenic mice for infertility in men. J. Endocrinol. Invest. 23:2000;584-591.
441. Veneroni O., Cocilovo L., Mueller E.E., Cocchi D. Delay of puberty and impairment of growth in female rats given a noncompetitive antagonist of NMDA receptors. Life Sci. 47:1990;1253-1260.
442. Wabitsch M., Blum W.F., Muche R., Braun M., Hube F., Rascher W.et al. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J. Clin. Invest. 100:1997;808-813.
443. Wade G.N., Schneider J.E., Li H.Y. Control of fertility by metabolic cues. Am. J. Physiol. 270:1996;E1-E19.
444. Walton W.J., Nguyen V.T., Butnev V.Y., Singh V., Moore W.T., Bousfield G.R. Characterization of human FSH isoforms reveals a nonglycosylated beta-subunit in addition to the conventional glycosylated beta-subunit. J. Clin. Endocrinol. Metab. 86:2001;3675-3685.
445. Wang M., Tam C.F., Kopple S., Kopple J.D. Monoamine and diamine oxidase activities in uremic rats. Life Sci. 17:1975;653-658.
446. Waxman D.J., Pampori N.A., Ram P.A., Agrawal A.K., Shapiro B.H. Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6868-6872.
447. Waxman D.J., Ram P.A., Park S.H., Choi H.K. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, STAT 5-related DNA binding protein. J. Biol. Chem. 270:1995;13262-13270.
448. Weiss J., Cronin M.J., Thorner M.O. Periodic interactions of GH-releasing factor and somatostatin can augment GH release in vitro. Am. J. Physiol. 253:1987;E508-E514.
449. Weltman A., Weltman J.Y., Hartman M.L., Abbott R.A., Rogol A.D., Evans W.S.et al. Relationship between age, percentage body fat, fitness and 24 h growth hormone release in healthy young adults: effects of gender. J. Clin. Endocrinol. Metab. 78:1994;543-548.
450. Wierson M., Long P.J., Forehand R.L. Toward a new understanding of early menarche: the role of environmental stress in pubertal timing. Adolescence. 28:1993;913-924.
451. Wilson M.E. IGF-I administration advances the decrease in hypersensitivity to oestradiol negative feedback inhibition of serum LH in adolescent female rhesus monkeys. J. Endocrinol. 145:1995;121-130.
452. Winer L.M., Shaw M.A., Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J. Clin. Endocrinol. Metab. 70:1990;1678-1686.
453. Winters S.J., Brufsky A., Weissfeld J., Trump D.L., Dyky M.A., Hadeed V. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism. 50:2001;1242-1247.
454. Winters J.S., Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and impairment in gonadotropin secretion. J. Clin. Endocrinol. Metab. 55:1982;560-565.
455. Woller M., Tessmer S., Neff D., Nguema A.A., Roo B.V., Waechter-Brulla D. Leptin stimulates gonadotropin releasing hormone release from cultured intact hemihypothalami and enzymatically dispersed neurons. Exp. Biol. Med. 226:2001;591-596.
456. Woller M.J., McDonald J.K., Reboussin D.M., Terasawa E. Neuropeptide Y is a neuromodulator of pulsatile luteinizing hormone-releasing hormone release in the gonadectomized rhesus monkey. Endocrinology. 130:1992;2333-2342.
457. Wong M.L., al-Shekhlee A., Bongiorno P.B., Esposito A., Khatri P., Sternberg E.M.et al. Localization of urocortin messenger RNA in rat brain and pituitary. Mol. Psychiatry. 1:1996;307-312.
458. Wu F.C., Butler G.E., Kelnar C.J., Huhtaniemi I., Veldhuis J.D. Patterns of pulsatile luteinizing hormone secretion from childhood to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay. J. Clin. Endocrinol. Metab. 81:1996;1798-1805.
459. Yiannakouris N., Yannakoulia M., Melistas L., Chan J.L., Klimis-Zacas D., Mantzoros C.S. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J. Clin. Endocrinol. Metab. 86:2001;4434-4439.
460. Yoshizato H., Tanaka M., Fujikawa T., Higashimoto Y., Shimizu A., Nakashima K. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells. Endocr. J. 47:2000;S37-S40.
461. Yu W.H., Kimura M., Walczewska A., Karanth S., McCann S.M. Role of leptin in hypothalamic-pituitary function. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1023-1028.
462. Zacharias L., Wurtman R.J. Age at menarche. Genetic and environmental influences. New Engl. J. Med. 280:1969;868-875.
463. Zacharias L., Wurtman R.J., Schatzoff M. Sexual maturation in contemporary American girls. Am. J. Obstet. Gynecol. 108:1970;833-846.
464. Zachmann M. Interrelations between growth hormones and sex hormones: physiology and therapeutic consequences. Horm. Res. 1:1992;1-8.
465. Zarinan T., Olivares A., Soderlund D., Mendez J.P., Ulloa-Aguirre A. Changes in the biological immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle. Hum. Reprod. 16:2001;1611-1618.
466. Zhou Y., Unterwald E.M., Ho A., LaForge K.S., Yuferov V.P., Kreuter J.et al. Ablation of pituitary pro-opiomelanocortin (POMC) cells produces alterations in hypothalamic POMC mRNA levels and midbrain mu opioid receptor binding in a conditional transgenic mouse model. J. Neuroendocrinol. 13:2001;808-817.
467. Zorrilla R., Simard J., Rheaume E., Labrie F., Pelletier G. Multihormonal control of pre-pro-somatostatin mRNA levels in the periventricular nucleus of the male and female rat hypothalamus. Neuroendocrinology. 52:1990;527-536.
468. Zumoff B., Strain G.W., Kream J., O'Connor J., Rosenfeld R.S., Levin J.et al. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men. J. Clin. Endocrinol. Metab. 54:1982;534-538.